Cagent Vascular
Signal active
Organization
Contact Information
Overview
Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease. Its commercialized angioplasty balloon with serration technology treats blocked arteries in the leg or peripheral artery disease and chronic limb-threatening ischemia.
About
Industries
Health Care, Medical, Medical Device
Founded
2014
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cagent Vascular headquartered in United States, North America, operates in the Health Care, Medical, Medical Device sector. The company focuses on Health Care and has secured $2.5B in funding across 48 round(s). With a team of 11-50 employees, Cagent Vascular is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Cagent Vascular, raised $500.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$51.9M
Details
3
Cagent Vascular has raised a total of $51.9M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 11.9M | ||
| 2024 | Late Stage Venture | 30.0M | ||
| 2016 | Seed | 500.0K |
Investors
Cagent Vascular is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cagent Vascular | - | FUNDING ROUND - Cagent Vascular | 30.0M |
| Blue Ridge Medical | - | FUNDING ROUND - Blue Ridge Medical | 30.0M |
| Cagent Vascular | - | FUNDING ROUND - Cagent Vascular | 500.0K |
| Ben Franklin Technology Partners of Southeastern Pennsylvania | - | FUNDING ROUND - Ben Franklin Technology Partners of Southeastern Pennsylvania | 500.0K |
Recent Activity
There is no recent news or activity for this profile.